Stock data
Evolent Health, Inc (EVH)
Evolent Health, Inc (EVH) reported revenue of US$1.88B and net income of -US$534.51M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$1.88B | — | -US$410.14M | -US$534.51M | — |
| 2024 | US$2.55B | — | -US$40.48M | -US$61.62M | — |
| 2023 | US$1.96B | — | -US$71.21M | -US$113.04M | — |
| 2022 | US$1.35B | — | US$3.64M | -US$19.16M | — |
| 2021 | US$907.96M | — | -US$42.41M | -US$37.60M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$652.52M | -US$28.36M | — |
| 2026-03-31 | US$496.25M | -US$26.63M | — |
| 2025-12-31 | US$468.72M | -US$429.13M | — |
| 2025-09-30 | US$479.53M | -US$20.86M | — |
| 2025-06-30 | US$444.33M | -US$19.90M | — |
| 2025-03-31 | US$483.65M | -US$64.62M | — |
| 2024-12-31 | US$646.54M | -US$22.80M | — |
| 2024-09-30 | US$621.40M | -US$23.14M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.